Understanding safety of glutamate in food and brain

Indian Journal of Physiology and Pharmacology

Volumn 51, Issue 3, 2007, Pages 216-234

  Mallick, H N ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Excitotoxicity; Glutamate; Monosodium glutamate; Neurotoxicity; Umami

Indexed keywords

FOOD ADDITIVE; GLUTAMIC ACID;

BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; HUMAN; HYPOXIA; ISCHEMIA; METABOLIC DISORDER; NERVE CELL LESION; NERVE DEGENERATION; NEUROTRANSMISSION; NONHUMAN; REVIEW; SAFETY; WORLD HEALTH ORGANIZATION;

ANIMALS; BLOOD-BRAIN BARRIER; FOOD ADDITIVES; GLUTAMIC ACID; HUMANS; MILK, HUMAN; NERVE DEGENERATION; SPECIES SPECIFICITY;

EID: 35048820000     PISSN: 00195499     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (116)

1. Ikeda K. Method of producing a seasoning material whose main component is glutamic acid. 1908; Japanese Pat No. 14: 805.
2. Ikeda K. On the taste of the salt of glutamic acid. J Tokyo Soc 1909; 30: 820-836.
3. Hayashi T. A physiological study of epileptic seizures following cortical stimulation in animals and its application to human clinics. Jpn J Physiol 1952; 3: 46-64.
4. Curtis DR, Watkins JC. The excitation and depression of spinal-neurones by structurally related amino acids. J Neurochem 1960; 6: 117-141.
5. Wurtman RJ. Summary In: Glutamic Acid: Advances in Biochemistry (Filer LJ. Garattini S. Kare MR. Reynolds WA. Wurtman RJ. Eds.), 1979; pp. 389-393. Raven Press, New York. NY.
6. Olney JW. Brain lesions, obesity and other disturbances in mice treated with monosodium glutamate. Science (Washington, DC) 1969; 164: 719-721.
7. Olney JW. Glutamate-induced retinal degeneration in neonatal mice. Electron microscopy of the acutely evolving lesion. J Neuropathol Exp Neurol 1969; 28: 455-474.
8. Lindermann B. Taste reception. Physiol Rev 1996; 76: 719-767.
9. Chaudhari N, Landin AM, Roper SD. A metabotropic glutamate receptor variant functions as a taste receptor. Nat Neurosci 2000; 3: 113-119.
10. Nelson G, Chandrashekar J, Hoon MA, Feng L, Zhao G, Ryba NJP, Zuker CS. An amino-acid taste receptor. Nature 2002; 416: 199-202.
11. Li N, Staszewski L, Xu H, Durick K, Zoller M, Adler E. Human receptors for sweet and umami taste. Proc Natl Acad Sci USA, 2002; 99: 4692-4696.
12. Zhao GQ, Zhang Y, Hoon MA, Chandrashekar J, Erlenbach I, Ryba NJP, Zuker CS. The receptors for mammalian sweet and umami taste. Cell 2003; 115: 255-266.
13. Damak S, Rong M, Yasumatsu K, Kokrashvili Z, Varadarajan V, Zou S, Jiang P, Ninomiya Y, Margolskee RF. Detection of sweet and umami taste in the absence of taste receptor T1r3. Science 2003; 301: 850-853.
14. Maruyama Y, Pereira E, Margolskee RF, Chaudhari N, Roper SD. Umami responses in mouse taste cells indicate more than one receptor. J Neurosci 2006; 26: 2227-2234.
15. Meldrum BS. Glutamate as a neurotransmitter in the brain : review of physiology and pathology. J Nutr 2000; 1007S-1015.
16. Meldrum BS. The role of glutamate in epilepsy and other CNS disorders. Neurology 1994; 44: (Suppl. 8) S14-S23.
17. Ninomiya K. Natural Occurrence, Food Reviews International 1998; 14: 177-211.
18. Yoshida Y. Umami Taste and Traditional Seasonings, Food Reviews international, 1998; 14: 213-246.
19. Davis T A, Nguyen HV, Garcia-Bravo R, Fiorotto ML, Jackson EM, Lewis DS, Lee DR, Reeds PJ. "Amino acid composition of human milk is not unique." J Nutr 1994; 124: 1126-1132.
20. Baker GL, Filer LJ Jr., Stegink LD. "Factors influencing dicarboxylic amino acid content of human milk." Glutamic Acid: Advances in Biochemistry and Physiology, edited by L. J. Filer, Jr., et al. 1979; pp. 111-124, Raven Press, New York.
21. Rassin DK, Sturman JA, Gaull GE. "Taurine and other free amino acids in milk of man and other mammals." Early Human Dev 1978; 2: 1-13.
22. Singh P, Saxena SK, Mallick HN. Free glutamic acid content of milk in Indian mothers. Indian J Physiol Pharmacol 2004; 48: 365-369.
23. Kare M, Kawamura Y. "UMAMI: A Basic Taste", 1987; Marcel Dekker Inc., N.Y.
24. Savarin B. "Physiogie du gout" Champs Flammarion, Paris 1982 ("The Physiology of Taste", 1852; translated into English by Fisher).
25. Schiffman SS, Gill JM. Psychophysical and neurophysiological taste responses to glutamate and purinergic compounds. In Kawamura, Y. and Kare, M.R. (eds), Umami: A Basic Taste. Marcel Dekker, New York, 1987; pp. 271-288.
26. Ninomiya Y, Funakoshi M. Qualitative discrimination among umami and the four basic taste substances in mice. In Kawamura, Y. and Kare, M.R. (eds), Umami: A Basic Taste. Marcel Dekker, New York, 1987; pp. 365-385.
27. San-Gabriel AM, Uneyama H, Maekawa T, Yoshie S, Torii K. The role of mGlur1 in rat taste and stomach tissue. Chem Senses 2006; 31: E90.
28. Ruiz CJ, Wray K, Delay E, Margolskee RF, Kinnamon SC. Behavioral evidence for a role of alpha-gustducin in glutamate taste. Chem Senses 2003; 28: 573-579.
29. Zhang Y, Hoon MA, Chandrashekar J, Mueller KL, Cook B, Wu D, Zuker CS, Ryba JP. Coding of sweet, bitter, and umami tastes: different receptor cells sharing similar signaling pathways. Cell 2003; 112: 293-301.
30. San Gabriel AM, Maekawa T, Uneyama H, Yoshie S, Torii K. mGluR1 in the fundic glands of rat stomach. FEBS Lett 2007; 581: 1119-1123.
31. Caulliez R, Viarouge C, Nicolaidis S. "Effect of umami taste of monosodium glutamate on early humoral and metabolic changes in the rat", in Olfaction and Taste XI, ed by Kurihara K, Suzuki N, and Ogawa H, Springer Verlag, New York 1994.
32. Munro Hamish N. "Factors in the Regulation of Glutamate Metabolism", pp. 55-68, in Glutamic Acid: Advances in Biochemistry and Physiology, ed. by L. J. Filer, Jr., et al., Raven Press, N.Y. 1979.
33. Reeds PJ, Burrin DG, Jahoor F, Wykes LJ, Henry J, Frazer E. Enteral glutamate is almost completely metabolized in first pass by the gastrointestinal tract of infant pig, Am J Physiol 1996; 270: E413-E418.
34. Tung TC, Tung KS. Serum free amino acid levels after oral glutamate intake in infant and adult humans. Nutrition Reports International 1980; 22: 431-443.
35. Neu J, Li N. Pathophysiology of glutamine and glutamate metabolism in premature infants. Curr Opin. Clin Nutr Metab Care 2007; 10: 75-79.
36. Oldendorf WH. Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection. Am J Physiol 1971; 221: 1629-1639.
37. Hawkins RA, DeJoseph MR, Hawkins PA. Regional brain glutamate transport in rats at normal and raised concentrations of circulating glutamate. Cell Tissue Res 1995; 281: 207-214.
38. Hawkins RA, Mans AM. Intermediary metabolism of carbohyadrate and other fuels In: Handbook of Neurochemistry (Lajtha A, ed) pp. 259-294, 1983.
39. Seal RP, Amara SG. Excitatory amino acid transporters: a family in flux. Annu Rev Pharmacol Toxicol 1999; 39: 431-456.
40. Hawkins RA, O Kane RL, Simpson IA, Vina JR. Structure of the blood brain barrier and its role in the transport of amino acids. J Nutr 2006; 136: 218S-226S.
41. Lee WJ, Hawkins RA, Vina JR, Peterson DR. Glutamine transport by the blood-brain barrier; a possible mechanism for nitrogen removal. Am J Physiol 1998; 274: 1101-1107.
42. Code of Federal Regulations, (2006), Title 21, Part 182. USA.
43. Glacometti T. Free and bound glutamate in natural products. In: Glutamic acid: Advances in Biochemistry (Filer LJ. Garattini S. Kare MR. Reynolds WA. Wurtman RJ. Eds.), 1979; pp. 25-34. Raven Press, New York.
44. Lucas DR, Newhouse JP. The toxic effect of sodium L-glutamate on the inner layers of the retina. AMA Arch Opthalmol 1957; 58: 193.
45. Choi DW. Glutamate neurotoxicity and disease of the nervous system. Neuron 1988; 1: 623-624.
46. Takasaki Y. Studies on brain lesions after administration of monosodium L-glutamate to mice. II Absence of brain damage following administration of monosodium L-glutamate in the diet. Toxicology 1978; 9: 307-318.
47. Takasaki Y, Matsuzawa Y, Iwata S, O'hara Y, Yonetani S, Ichimura M. Toxicological studies of monosodium L-glutamate in rodents; relationship between routes of administration and neurotoxicity. In: Glutamic Acid: Advances in Biochemistry (Filer LJ. Garattini S. Kare MR. Reynolds WA. Wurtman RJ. Eds.), 1979; pp. 255-275. Raven Press, New York.
48. Pitkin RM, Reynolds WA, Stegink LD, Filer LJ Jr. Glutamate metabolism and placental transfer in pregnancy. Filer LJ, Garattini S, Kare MR, Reynolds WA, Wurtman RJ. eds. Glutamic Acid: Advances in Biochemistry 1979: 103-110 Raven Press New York.
49. Heywood R, James RW, Worden AN. The ad libitum feeding of monosodium glutamate to weanling mice. Toxicol Lett 1977; 1: 151-155.
50. Heywood R, Worden AN. Glutamate toxicity in laboratory animals. (Filer LJ, Garattini S, Kare MR, Reynolds WA, Wurtman RJ. eds.) Glutamic Acid: Advances in Biochemistry, pp. 203-215, Raven Press, New York.
51. Airoldi L, Bonfanti M, Ghezzi P, Salmona M, Garattini S. Effect of oral monosodium glutamate on glutamic acid levels in the nucleus arcuatus of the hypothalamus and on serum osmolality of adult and infant mice. Toxicol Lett 1980; 7: 107-111.
52. Airoldi L, Garattini S. Glutamic acid and sodium levels in the nucleus arcuatus of the hypothalamus of adult and infant guinea pigs after oral monosodium glutamate. Toxicol Lett 1979; 4: 313-316.
53. Monno A, Vezzani A, Bastone A, Salmona M, Garattini S. Extracellular glutamate levels in the hypothalamus and hippocampus of rats after acute or chronic oral intake of monosodium glutamate. Neurosci Lett 1995; 193: 45-48.
54. Ullensvang K, Lehre KP, Storm-Mathisn J, Danbolt NC. Differential developmental expression of the two rat brain glutamate transporter proteins GLAST and GLT. Eur J Neurosci 1997; 9: 1646-1655.
55. Zhou M, Baudry M. Developmental changes in NMDA neurotoxicity reflect developmental changes in subunit composition of NMDA receptor. J Neurosci 2006: 2956-2963.
56. Reynolds WA, Lemkey-Johnston N, Stegink LD. Morphology of the fetal monkey hypothalamus after in utero exposure to monosodium glutamate. Filer LJ, Garattini S, Kare MR, Reynolds WA, Wurtman RJ. eds. Glutamic Acid: Advances in Biochemistry 1979: 217-229 Raven Press New York, NY.
57. Kwok RHM. Chinese-restaurant syndrome. New Engl J Med 1968; 278: 296.
58. Geha RS, et al. "Multicenter, double-blind, placebo-controlled, multiple-challenge evaluation of reported reactions to monosodium glutamate." J Allergy Clin Immunol 2000; 106: 973-980.
59. Thirty-first Report of the Joint FAO/WHO Expert Committee on Food Additives, WHO Technical Report Series, No. 759, 1987; 10-11, 29-31.
60. Report of the Scientific Committee for Food (Twenty-fifth series), Commission of the European Communities, 1991; 7-16.
61. Analyses of Adverse Reactions to Monosodium Glutamate (MSG), prepared by the Life Sciences research Office, Federation of American Societies for Experimental Biology, published by American Institute of Nutrition, 1995; 14-15.
62. Proceedings of the Symposium on Safety and Usefulness of Glutamate as a Flavour Enhancer: current state of the knowledge, Edited by V. Prakash et al, 1999; 130-132.
63. Schlett K. Glutamate as a modulator of embryonic and adult neurogenesis. Curr Top Med Chem 2006; 6: 949-960.
64. Lujan R, Shigemoto R, Lopez-Bendito G. Glutamate and GABA receptor signalling in the developing brain. Neuroscience 2005; 130: 567-580.
65. Platt SR. The role of glutamate in central nervous system health and disease-a review. Vet J 2007; 173: 278-286.
66. Hamburger A et al. Glutamate as a CNS transmitter. II regulation of synthesis in the released pool. Brain Res Rev al 1979; 168: 531-541.
67. Broer S, Brookes N. Transfer of glutamte between astrocyte and neurons. J Neurochem 2000; 77: 705-719.
68. Chaudhry FA, Reimer RJ, Edwards RH. The glutamine commute: take the N line and transfer to the A. J Cell Biol 2002; 157: 349-355.
69. Takamori S, Rhee JS, Rosenmund C, Jahn R. Identification of a vesicular glutamate transporter that defines a glutamatergic phenotype in neurons. Nature 2000; 407: 189-194.
70. Takamori S. VGLUTs: 'exciting times for glutamatergic research? Neurosci Res 2006; 55: 343-351.
71. Nakamura K, Wu SX, Fujiyama F, Okamoto K, Hioki H, Kancko T. Independent inputs of VGLUT2- and VGLUT3-positive glutamatergic terminals onto rat sympathetic preganglionic neurons. Neuroreport 2004; 15: 431-436.
72. Fyk-Kolodziej B, Dzhagaryan A, Qin P, Pourcho RG. Immunocytochemical localization of three vesicular glutamate transporters in the cat retina. J Comp Neurol 2004; 475: 518-530.
73. Trudeau LE. Glutamate co-transmission as an emerging concept in monoamine neuron function. J Psychiatry Neurosci 2004; 29: 296-310.
74. Hayashi M, Morimoto R. Yamamoto A, Moriyama Y. Expression and localization of vesicular glutamate transporters in pancreatic islets, upper gastrointestinal tract, and testis. J Histochem Cytochem 2003; 51: 1375-1390.
75. Nakanishi S. Molecular diversity of glutamate receptors and implications for brain function. Science 1992; 258: 597-604.
76. McBain CJ, Mayer ML. N-Methyl-D-Aspartic Acid receptor: Structure and functions. Physiol Rev 1994; 74: 723-759.
77. Greenamyre JT. Anatomy and physiology of glutamate in the CNS. Neurology 1994; 44: (S) S7-S13.
78. Johnson JW, Ascher P. Equilibrium and kinetic study of glycine action on the N-methyl-D-aspartate receptor in cultured mouse brain neurons. J Physiol (Lond) 1992; 455: 339-365.
79. Nowak L, Bregestovski P, Ascher P. Magnesium gates glutamate activated channels in mouse central neurons. Nature 1984; 307: 462-465
80. + of responses in spinal cord neurons. Nature 1984; 309: 261-263.
81. Cik M, Chazot PL, Stephenson FA. Optimal expression of cloned NMDAR1/NMDAR2A heteromeric glutamate receptors; a biochemical characterization. Biochem J 1993; 296: 877-883.
82. Kanai Y, Smith CP, Hediger MA. A new family of neurotransmitter transporters; the high affinity glutamate transporters. FASEB J 1994; 8: 1450-1459.
83. Takahashi M, Billups B, Rossi D, Sarantis M, Hamann M, Attwell D. The role of glutamate transporters in glutamate homeostasis in the brain. J Exp Biol 1997; 200: 401-409.
84. Shigeri Y, Seal RP, Shimamoto K. Molecular pharmacology of glutamate transporters, EAATs and VGLUTs. Brain Res Brain Res Rev 2004; 45: 250-265.
85. Beart PM, O'Shea RD Transporters of L-glutamate: an update on their molecular pharmacology and pathological involvement. Br J Pharmacol 2007; 150: 5-17.
86. Herzog E, Takamori S, Jahn R, Brose N, Wojcik SM. Synaptic and vesicular co-localization of the glutamate transporters VGLUTI and VGLUT2 in the mouse hippocampus. J Neurochem 2006; 99: 1011-1018.
87. Fremeau RT, Voglmaier S, Seal RP, Edwards RH. VGLUTs define subsets of excitatory neurons and suggest novel roles for glutamate. Trends Neurosci 2004; 27: 98-103.
88. Oshima T, Rossi D, Anwell D. Release of glutamate by reversed uptake during ischaemia of rat hippocampal cultures. Eur J Neurosci 1988; 10-205.
89. Szatkowski M, Attwell D. Triggering and execution of neuronal death in brain ischaemia: two phases of glutamate release by different mechanisms. Trends Neurosci 1994; 17: 359-365.
90. Drejer J, Benveniste H, Diemer HN, Schousboe A. Cellular origin of ischemia-induced glutamate release from brain tissue in vivo and in vitro. J Neurochem 1985; 45: 145-151.
91. Roettger V, Lipton P. Mechanism of glutamate release from rat hippocampal slices during in vitro ischemia. Neuroscience 1996; 75: 677-685.
92. Martin LJ, Brambrink AM, Lehmann C, Portera-Cailliau C, Koethler R. et al. Hypoxia-ischemia causes abnormalities in glutamate transporters and death of astroglia and neurons in newborn striatum. Ann Neurol 1997; 42: 335-348.
93. Miller HP, Levey AI, Rothstein JD, Tzingounis AV, Conn PJ. Alterations in glutamate transporter protein levels in kindling induced epilepsy. J Neurochem 1997; 68: 1564-1570.
94. Nonaka M, Kohmura E, Yamashita T, Shimada S, Tanaka K, Yoshimane T, Tohyama M, Hayakawa T. Increased transcription of glutamate-aspartate transporter (GLAST Glu T-1) mRNA following kainic acid-induced limbic seizure. Mol Brain Res 1998; 55: 54-60.
95. Li S, Mallory M, Alford M, Tanaka S, Masliah E. Glutamate transporter alterations in Alzheimer disease are possibly associated with abnormal expression. J Neuropathol Exp Neurol 1997; 56: 901-911.
96. Masliah E. Mechanisms of synaptic pathology in Alzheimer's disease. J Neurol Transm Suppl 1998; 53: 147-168.
97. Rothstein JD, Martin IJ, Kuncl RW. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N Engl J Med 1992; 326: 1464-1468.
98. Rothstein JD. Excitotoxic mechanisms in the pathogenesis of amyotrophic lateral sclerosis. In pathogenesis and Therapy of Amyotrophic Lateral Sclerosis. Ed. G. Serratrice. T Munsat. 1995; 68: 7-20. Philadelphia Lippincott-Raven.
99. Rothstein JD, Van Kammen M, Levey AI, Martin IJ, Kuncl RW. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol 1995; 38: 73-84.
100. Bristol LA, Rothstein JD. Glutamate transporter gene expression in amyotrophic lateral sclerosis motor cortex. Ann Neurol 1996; 39: 676-679.
101. Brown JI, Baker AJ, Konasiewicz SJ, Moulton RJ. Clinical significance of CSF glutamate concentrations following severe traumatic brain injury in humans. J Neurotrauma 1998; 15: 253-263.
102. Budd SL. Mechanisms of neuronal damage in brain hypoxia/ischemia: focus on the role of mitochondrial calcium accumulation. Pharmacol Ther 1998; 80: 203-229.
103. Nadergaard M. Mechanisms of brain damage in focal cerebral ischemia. Acta Neurol Scand 1988; 77: 81-101.
104. Mills LR, Kater SB. Neuron-specific and state-specific differences in calcium homeostasis regulate the generation and degeneration of neuronal architecture. Neuron 1990; 4: 149-163.
105. Sattler R, Tymianski M. Molecular mechanisms of calcium-dependent excitotoxicin. J Mol Med 2000; 78: 3-13.
106. Arundine M, Tymianski M. Molecular mechanisms of calcium dependent neurodegenration in excitotoxicity. Cell Calcium 2003; 34: 325-337.
107. Matson MP. Calcium and neurodegenration. Aging Cell 2007; 6: 337-350.
108. Lipton SA, Singel DJ, Stamler JS. Nitric oxide in the central nervous system. Prog Brain Res 1994; 103: 359-364.
109. Christopherson KS, Bredt DS. Nitric oxide in excitable tissues: physiological roles and disease. J Clin Invest 1997; 100: 2424-2429.
110. Dawson VL, Dawson TM. Nitric oxide in neurodegeneration. Prog Brain Res 1998; 118: 215-229.
111. Torreilles F, Salman-Tabcheh S, Guerin M, Torreilles J. Neurodegenerative disorders: the role of peroxynitrite. Brain Res Brain Res Rev 1999; 30: 153-163.
112. Lipton SA. Neuronal protection and destruction by NO. Cell Death Differentiat 1999; 6: 943-951.
113. Albin RL, Greenmyre JT, Alternative excitiotoxic hypothesis. Neurology, 1992; 42: 732-738.
114. Lipton SA, Rosenberg PA. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 1994; 330: 613-622.
115. Vesce S, Rossi D, Brambilla L, Volterra A. Glutamate release from astrocytes in physiological conditions and in neurodegenerative disorders characterized by neuroinflammation. Int Rev Neurobiol 2007; 82: 57-71.
116. Beyreuther K, Biesalski HK, Fernstorm JD, Grimm P, Hammes WP, Heinemann U, Kempski O, Steinhart H, Walker R. Consensus meeting: monosodium glutamate-an update. Eur J Clin Nutr 2007; 61: 304-313.